ANDREW LEE to Treatment Outcome
This is a "connection" page, showing publications ANDREW LEE has written about Treatment Outcome.
Connection Strength
0.436
-
Risk of consecutive esotropia after surgery for intermittent exotropia according to passive duction force. PLoS One. 2023; 18(2):e0281392.
Score: 0.065
-
Deep learning synthetic angiograms for individuals unable to undergo contrast-guided laser treatment in aggressive retinopathy of prematurity. Eye (Lond). 2023 09; 37(13):2834-2835.
Score: 0.065
-
Ocular Myasthenia Gravis 32 years From Remission to Relapse. J Neuroophthalmol. 2023 06 01; 43(2):e45-e46.
Score: 0.059
-
The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis. J Neuroophthalmol. 2021 Sep 01; 41(3):342-350.
Score: 0.059
-
Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial. Toxins (Basel). 2021 01 21; 13(2).
Score: 0.057
-
Orbital AL amyloid. Orbit. 2020 Feb; 39(1):68-70.
Score: 0.050
-
Systemic corticosteroids in nonarteritic ischemic optic neuropathy. Indian J Ophthalmol. 2014 Oct; 62(10):1022-4.
Score: 0.037
-
Should steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy? J Neuroophthalmol. 2010 Jun; 30(2):193-8.
Score: 0.027
-
Point Counter-Point: Thymectomy in Ocular Myasthenia Gravis. J Neuroophthalmol. 2022 12 01; 42(4):541-546.
Score: 0.016